课题基金 / 基金详情

'Partial' Rodent Model for GABA Defect in Schizophrenia

'Partial' Rodent Model for GABA Defect in Schizophrenia
精神分裂症 GABA 缺陷的“部分”啮齿动物模型
批准号:
7162161
负责人:
Sabina Berretta
金额:
$20.61万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2004
资助国家:
美国
项目状态:
已结题
起止时间:
2004-01-13 至 2008-12-31
关键词:
AffectAgeAkinetic MutismAmygdaloid structureAnimal ModelAnteriorAutopsyBehavioralBicucullineBilateralBiological AssayBrain imagingBrain regionCalcium-Binding ProteinsCannulasCarboxy-LyasesCellsCholecystokininChronicClassificationClinicalComplexConsensusContinuous InfusionDefectDepthDevelopmentDiseaseDisruptionDissectionDorsalDoseEmotionalEmotionsExperimental DesignsExperimental ModelsFaceFacial ExpressionFunctional disorderGlobus PallidusGlutamate ReceptorGlutamatesGoalsHallucinationsHippocampus (Brain)HumanImpairmentIn Situ HybridizationInfarctionInfusion proceduresInterneuronsInvestigationLesionLightLinkMeasuresMedialMedial Dorsal NucleusMessenger RNAMethodsMicroscopicModelingN-Methyl-D-Aspartate ReceptorsN-MethylaspartateNR1 geneNeuronsNucleus AccumbensOutcome MeasureParvalbuminsPathogenesisPeptidesPharmaceutical PreparationsPhysiologicalPicrotoxinPlacementPlayPopulationPrefrontal CortexPrincipal InvestigatorProcessProtein IsoformsProteinsRattusReportingRodent ModelRoleSchizophreniaSensorySeveritiesSimulateSiteSolidSourceSymptomsTemporal LobeTestingThalamic structureThinkingTimeVentral Tegmental AreaWeekWithdrawalWorkalpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acidamino 3 hydroxy 5 methylisoxazole 4 propionatebasebehavior testcalbindin-D28Kcalretinincingulate gyrusdaydensitydesigndopamine systementorhinal cortexexperiencegamma-Aminobutyric Acidhuman NR1 proteinimmunocytochemistryinsightmRNA Expressionneural circuitneurochemistryneuronal circuitrypars compactapostnatalprepulse inhibitionprogramsreceptorreceptor expressionresearch studyresponseselective attentionsocialsocial communicationtransmission processuptake

项目摘要

项目成果

Sabina Berretta的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): There is growing consensus that multiple limbic regions, including the anterior cingulate gyrus (ACG) and amygdala, are involved in the pathophysiology of schizophrenia. The aim of the proposed investigations is to use a 'partial' rodent model to dissect out, from a complex network of corticolimbic circuitry, one potential source of abnormal input to other limbic brain regions, and to investigate its effects using cytochemical assays and behavioral testing. In particular, these studies are focused on the hypothesis that, in schizophrenia, abnormalities in ACG may, in turn, induce secondary changes in amygdala. ACG and amygdala are massively interconnected and their role in the pathophysiology of schizophrenia is gaining growing support. Solid evidence indicates the presence in ACG of a disruption of GABAergic transmission. In these studies, such a disruption will be mimicked pharmacologically by local chronic infusion of a GABAA receptor antagonist in the ACG of young rats. Neurochemical changes induced in amygdala will be investigated using a time-course experimental design. In particular, densities of neurons expressing ionotropic glutamate receptors and glutamate amino decarboxylase (in situ hybridization and immunocytochemistry) and neuronal subpopulations expressing glutamate, GABA or the calcium binding proteins parvalbumin, calretinin or calbindin D28k (immunocytochemistry) will be measured in each amygdalar subdivision following 1, 2, 4 weeks of chronic, continuous, infusion of a GABAA receptor antagonist in ACG or 3 months after the end of a 4 weeks treatment. These neurochemical changes will be then correlated to measures of startle responsivity in order to assess the validity of this model in reproducing behavioral deficits described in schizophrenia. The combination of these methods will work synergistically to shed light on inter-related changes within distinct neural circuitry and their effect on lasting behavioral abnormalities. The significance of these studies resides in their potential of providing functional links between neurochemical abnormalities in schizophrenia detected in interconnected limbic brain regions.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Discovery of the Rostromedial Tegmental Nucleus in the Human Brain
  • 批准号:
    10559693
  • 项目类别:
  • 资助金额:
    $24.6万
  • 财政年份:
    2022
  • 负责人:
    Sabina Berretta
  • 依托单位:
Discovery of the Rostromedial Tegmental Nucleus in the Human Brain
  • 批准号:
    10452303
  • 项目类别:
  • 资助金额:
    $20.5万
  • 财政年份:
    2022
  • 负责人:
    Sabina Berretta
  • 依托单位:
Dysregulation of Appetitive & Aversive Amygdala Circuits in Bipolar Disorder
  • 批准号:
    10579190
  • 项目类别:
  • 资助金额:
    $77.36万
  • 财政年份:
    2020
  • 负责人:
    Sabina Berretta
  • 依托单位:
Dysregulation of Appetitive & Aversive Amygdala Circuits in Bipolar Disorder
  • 批准号:
    10372144
  • 项目类别:
  • 资助金额:
    $78.45万
  • 财政年份:
    2020
  • 负责人:
    Sabina Berretta
  • 依托单位:
国内基金
海外基金
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
  • 批准号:
    JCZRQN202500010
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
  • 依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
  • 批准号:
    2025JJ70209
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    雷芬芳
  • 依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
  • 批准号:
    --
  • 项目类别:
    面上项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    万荣
  • 依托单位: